Felipe Pinheiro

Mr. Felipe Pinheiro

Universidade Federal Fluminense (UFF)
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2020 in Toxins
Verified
Journal Article
Open access
PDF file
TMThamiris Santana Machado
Thamiris Santana Machado
FPFelipe Pinheiro
Felipe Pinheiro
LALialyz Soares Pereira André
Lialyz Soares Pereira André
RENATA PEREIRARENATA PEREIRA
RENATA PEREIRA
RCReginaldo Fernandes Correa
Reginaldo Fernandes Correa
Fabio Aguiar-AlvesFabio Aguiar-Alves
Fabio Aguiar-Alves
Hospitalizations related to Methicillin-resistant Staphylococcus aureus (MRSA) are frequent, increasing mortality and health costs. In this way, this study aimed to compare the genotypic and phenotypic characteristics of MRSA isolates that colonize and infect patients seen at two hospitals in the city of Niterói—Rio de Janeiro, Brazil. A total of 147 samples collected between March 2013 and December 2015 were phenotyped and genotyped to identify the protein A (SPA) gene, the mec staphylococcal chromosomal cassette (SCCmec), mecA, Panton-Valentine Leucocidin (PVL), icaC, icaR, ACME, and hla virulence genes. The strength of biofilm formation has also been exploited. The prevalence of SCCmec type IV (77.1%) was observed in the colonization group; however, in the invasive infection group, SCCmec type II was prevalent (62.9%). The Multilocus Sequence Typing (MLST), ST5/ST30, and ST5/ST239 analyses were the most frequent clones in colonization, and invasive infection isolates, respectively. Among the isolates selected to assess the ability to form a biofilm, 51.06% were classified as strong biofilm builders. Surprisingly, we observed that isolates other than the Brazilian Epidemic Clone (BEC) have appeared in Brazilian hospitals. The virulence profile has changed among these isolates since the ACME type I and II genes were also identified in this collection.

29 July 2020 in Letters in Applied Microbiology
Verified
Journal Article
Open access
PDF file
Luiz Carlos da Silva PinheiroLuiz Carlos da Silva Pinheiro
Luiz Carlos da Silva Pinheiro
LHLucas V.B. Hoelz
Lucas V.B. Hoelz
MFMaria de Lourdes G. Ferreira
Maria de Lourdes G. Ferreira
LOLarissa G. Oliveira
Larissa G. Oliveira
RENATA PEREIRARENATA PEREIRA
RENATA PEREIRA
Fabio Aguiar-AlvesFabio Aguiar-Alves
Fabio Aguiar-Alves
Following the appearance of several antimicrobial agents to control the spread of infections, two major challenges have emerged: 1‐ the occurrence and blowout of multiresistant bacteria and the increase of chronic diseases, and 2‐ difficult‐to‐eradicate infections. In this study, we tested five benzoylthiourea derivatives for their ability to inhibit and stop bacterial growth and evaluated the possible influence of 1,2,4‐triazolyl‐benzoylthiourea derivative 4 on the formation and eradication of S. aureus biofilms. Benzoylthiourea derivatives 4 , 6 , 10 , 11, and 13 were obtained in one or two steps with low cost and subjected to tests to identify their minimum inhibitory concentration and minimum bactericidal concentration. In vitro tests were also performed to assess their effects on biofilm formation and in preformed biofilms and scanning electron microscopy was used to visualize the effects on biofilm formation. The 1,2,4‐triazolyl‐benzoylthiourea derivative 4 showed bacteriostatic activity against the Staphylococcus aureus HU25 clinical strain with an minimum inhibitory concentration (MIC) of 16 µg.mL‐1, which is below the toxic concentration (at 2,500 µg.mL‐1, 62.25% of the cells remained viable). Compound 4 also effectively prevented biofilm formation at the three subinhibitory concentrations tested (1/2 MIC, 1/4 MIC and 1/8 MIC) as confirmed by SEM. For breakdown of formed biofilms, the main influence was at a subinhibitory concentration (1/2 MIC). These findings make compound 4 a strong candidate for studies on the development of new antimicrobial and antibiofilm agents.

5 November 2025 in bioRxiv
Verified
Preprint
Open access
NANicolas da Matta Freire Araujo
Nicolas da Matta Freire Araujo
MCMárcia da Silva Chagas
Márcia da Silva Chagas
MSMateus Fernandes Santos
Mateus Fernandes Santos
RENATA PEREIRARENATA PEREIRA
RENATA PEREIRA
RBRafaela Correia Brum
Rafaela Correia Brum
FSFabrício Alves Barbosa da Silva
Fabrício Alves Barbosa da Silva
Antimicrobial resistance constitutes an escalating global health threat, complicating therapeutic management and increasing morbidity and mortality. Deep learning approaches have emerged as promising tools for bacterial profiling based on omics data, particularly for predicting antimicrobial susceptibility from genomic information. This task relies on identifying genomic signatures associated with resistance mechanisms. Here, DeepMDC is introduced as a deep learning architecture designed for bacterial profiling using whole-genome data. Given that precise annotation at the gene or mutation level is often costly and ambiguous, phenotypic classification is formulated as a Multiple Instance Learning (MIL) problem, in which each genome is represented as a bag of instances with a single associated label. The core of DeepMDC is a Modern Hopfield Network that processes all open reading frames (ORFs), including small ones, derived from genomic data. A key feature of the architecture is its interpretability, enabled by attention mechanisms that facilitate biological insight and hypothesis generation. The model was evaluated against Klebsiella pneumoniae and four clinically relevant antibiotics (meropenem, cefepime, ceftazidime, and gentamicin), achieving strong performance in several metrics. Notably, genes associated with resistance consistently received high attention scores during inference, which validates the architecture and eventually may generate new hypotheses.

21 February 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Rodrigo Cuiabano Paes LemeRodrigo Cuiabano Paes Leme
Rodrigo Cuiabano Paes Leme
FPFelipe Pinheiro
Felipe Pinheiro
RENATA PEREIRARENATA PEREIRA
RENATA PEREIRA
Fabio Aguiar-AlvesFabio Aguiar-Alves
Fabio Aguiar-Alves
S. aureus is an alarming human pathogen since it triggers numerous diseases, including impetigo and pneumonia. The S. aureus' ability to colonise the upper respiratory tract and other tissues, such as the skin, throat and gut, operate as reservoirs for infection. Indeed, being a carrier of S. aureus in the gut represents a risk factor for developing infection in distinct sites, including an unusual gastrointestinal tract disease. Here, we present an atypical clinical course of staphylococcal enterocolitis (SEC) in a man in his early seventies. After an unforeseen identification of methicillin-resistant Staphylococcus aureus (MRSA), the oral administration of vancomycin was critical in the outcome of the case. Although infrequent, SEC is an underestimated disease and requires a chapter in the treatment recommendations for antibiotic-related diarrhoea. Awareness of the risk factors and diagnostic tests, along with including SEC in algorithms for handling antibiotic-associated diarrhoea, is a step towards new epidemiological information.